Loading…
Fragmented responsibility: views of Israeli HCPs regarding patient recontact following variant reclassification
While genomic medicine is becoming an important part of patient care with an ever-increasing diagnostic yield, recontacting patients after reclassification of variants of uncertain clinical significance (VUSs) remains a major challenge. Although periodical reinterpretation of VUSs is highly desired,...
Saved in:
Published in: | Journal of community genetics 2022-02, Vol.13 (1), p.13-18 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c474t-867792e8ccf67a29ee6335ac747256c91d7c872c8a1b6933d5fae8535c8dd9ee3 |
---|---|
cites | cdi_FETCH-LOGICAL-c474t-867792e8ccf67a29ee6335ac747256c91d7c872c8a1b6933d5fae8535c8dd9ee3 |
container_end_page | 18 |
container_issue | 1 |
container_start_page | 13 |
container_title | Journal of community genetics |
container_volume | 13 |
creator | Fridman, Alma Levin Raz, Aviad Timmermans, Stefan Shkedi-Rafid, Shiri |
description | While genomic medicine is becoming an important part of patient care with an ever-increasing diagnostic yield, recontacting patients after reclassification of variants of uncertain clinical significance (VUSs) remains a major challenge. Although periodical reinterpretation of VUSs is highly desired, recontacting former patients with new classifications is commonly not fulfilled in practice. We draw on semi-structured interviews with 20 Israeli healthcare professionals and stakeholders involved in communicating the results of genome-wide sequencing to patients. Findings show agreement that an individual health care professional cannot address the task of recontacting patients after re-classification, and that responsibility should be shared among the medical specialties, laboratory scientists, as well as patients. In the absence of established guidelines, many respondents suggested that the patient should be informed about reclassification during a follow-up contact but they disagreed who should be responsible for informing the patient. HCPs agreed that the solution to this challenge involves a centralized automated database that is accessible, continuously updated, and facilitates retrospective as well as prospective flagging of reclassification for patients who can benefit from this information. National and international policies providing concrete guidelines on the optimal way to recontact patients with new valuable genomic information are needed. |
doi_str_mv | 10.1007/s12687-021-00556-x |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8491183</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2579379892</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-867792e8ccf67a29ee6335ac747256c91d7c872c8a1b6933d5fae8535c8dd9ee3</originalsourceid><addsrcrecordid>eNp9kctuFDEQRS0URKKQH2ARtcQmmwY_2i8WSGiUlxQJFiCxs2rc7o4jjz3YPZPk7-PQQ4As4o0t31O3qnQRekfwB4Kx_FgIFUq2mJIWY85Fe_cKHRAlVCswJnu7NyP45z46KuUG18MY4YK_QfusE1hLSg5QOsswrlycXN9kV9YpFr_0wU_3n5qtd7elSUNzWTK44JuLxbdSqRFy7-PYrGHytbL-2BQnsFMzpBDS7aO2hexh1gKU4gdvK53iW_R6gFDc0e4-RD_OTr8vLtqrr-eXiy9Xre1kN7VKSKmpU9YOQgLVzgnGOFjZScqF1aSXVklqFZCl0Iz1fACnOONW9X2l2SH6PPuuN8uV622dM0Mw6-xXkO9NAm_-V6K_NmPaGtVpQhSrBic7g5x-bVyZzMoX60KA6NKmGMqlZlIrTSv6_hl6kzY51vUMFZQJXOfilaIzZXMqJbvhaRiCzWOkZo7U1EjN70jNXS06_neNp5I_AVaAzUCpUhxd_tv7BdsHVciv8A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2623605355</pqid></control><display><type>article</type><title>Fragmented responsibility: views of Israeli HCPs regarding patient recontact following variant reclassification</title><source>Open Access: PubMed Central</source><source>Springer Nature</source><creator>Fridman, Alma Levin ; Raz, Aviad ; Timmermans, Stefan ; Shkedi-Rafid, Shiri</creator><creatorcontrib>Fridman, Alma Levin ; Raz, Aviad ; Timmermans, Stefan ; Shkedi-Rafid, Shiri</creatorcontrib><description>While genomic medicine is becoming an important part of patient care with an ever-increasing diagnostic yield, recontacting patients after reclassification of variants of uncertain clinical significance (VUSs) remains a major challenge. Although periodical reinterpretation of VUSs is highly desired, recontacting former patients with new classifications is commonly not fulfilled in practice. We draw on semi-structured interviews with 20 Israeli healthcare professionals and stakeholders involved in communicating the results of genome-wide sequencing to patients. Findings show agreement that an individual health care professional cannot address the task of recontacting patients after re-classification, and that responsibility should be shared among the medical specialties, laboratory scientists, as well as patients. In the absence of established guidelines, many respondents suggested that the patient should be informed about reclassification during a follow-up contact but they disagreed who should be responsible for informing the patient. HCPs agreed that the solution to this challenge involves a centralized automated database that is accessible, continuously updated, and facilitates retrospective as well as prospective flagging of reclassification for patients who can benefit from this information. National and international policies providing concrete guidelines on the optimal way to recontact patients with new valuable genomic information are needed.</description><identifier>ISSN: 1868-310X</identifier><identifier>EISSN: 1868-6001</identifier><identifier>DOI: 10.1007/s12687-021-00556-x</identifier><identifier>PMID: 34609721</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Epidemiology ; Gene Function ; Gene Therapy ; Genomics ; Health care ; Human Genetics ; Original ; Original Article ; Patients ; Public Health ; Reclassification</subject><ispartof>Journal of community genetics, 2022-02, Vol.13 (1), p.13-18</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-867792e8ccf67a29ee6335ac747256c91d7c872c8a1b6933d5fae8535c8dd9ee3</citedby><cites>FETCH-LOGICAL-c474t-867792e8ccf67a29ee6335ac747256c91d7c872c8a1b6933d5fae8535c8dd9ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491183/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491183/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34609721$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fridman, Alma Levin</creatorcontrib><creatorcontrib>Raz, Aviad</creatorcontrib><creatorcontrib>Timmermans, Stefan</creatorcontrib><creatorcontrib>Shkedi-Rafid, Shiri</creatorcontrib><title>Fragmented responsibility: views of Israeli HCPs regarding patient recontact following variant reclassification</title><title>Journal of community genetics</title><addtitle>J Community Genet</addtitle><addtitle>J Community Genet</addtitle><description>While genomic medicine is becoming an important part of patient care with an ever-increasing diagnostic yield, recontacting patients after reclassification of variants of uncertain clinical significance (VUSs) remains a major challenge. Although periodical reinterpretation of VUSs is highly desired, recontacting former patients with new classifications is commonly not fulfilled in practice. We draw on semi-structured interviews with 20 Israeli healthcare professionals and stakeholders involved in communicating the results of genome-wide sequencing to patients. Findings show agreement that an individual health care professional cannot address the task of recontacting patients after re-classification, and that responsibility should be shared among the medical specialties, laboratory scientists, as well as patients. In the absence of established guidelines, many respondents suggested that the patient should be informed about reclassification during a follow-up contact but they disagreed who should be responsible for informing the patient. HCPs agreed that the solution to this challenge involves a centralized automated database that is accessible, continuously updated, and facilitates retrospective as well as prospective flagging of reclassification for patients who can benefit from this information. National and international policies providing concrete guidelines on the optimal way to recontact patients with new valuable genomic information are needed.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Epidemiology</subject><subject>Gene Function</subject><subject>Gene Therapy</subject><subject>Genomics</subject><subject>Health care</subject><subject>Human Genetics</subject><subject>Original</subject><subject>Original Article</subject><subject>Patients</subject><subject>Public Health</subject><subject>Reclassification</subject><issn>1868-310X</issn><issn>1868-6001</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kctuFDEQRS0URKKQH2ARtcQmmwY_2i8WSGiUlxQJFiCxs2rc7o4jjz3YPZPk7-PQQ4As4o0t31O3qnQRekfwB4Kx_FgIFUq2mJIWY85Fe_cKHRAlVCswJnu7NyP45z46KuUG18MY4YK_QfusE1hLSg5QOsswrlycXN9kV9YpFr_0wU_3n5qtd7elSUNzWTK44JuLxbdSqRFy7-PYrGHytbL-2BQnsFMzpBDS7aO2hexh1gKU4gdvK53iW_R6gFDc0e4-RD_OTr8vLtqrr-eXiy9Xre1kN7VKSKmpU9YOQgLVzgnGOFjZScqF1aSXVklqFZCl0Iz1fACnOONW9X2l2SH6PPuuN8uV622dM0Mw6-xXkO9NAm_-V6K_NmPaGtVpQhSrBic7g5x-bVyZzMoX60KA6NKmGMqlZlIrTSv6_hl6kzY51vUMFZQJXOfilaIzZXMqJbvhaRiCzWOkZo7U1EjN70jNXS06_neNp5I_AVaAzUCpUhxd_tv7BdsHVciv8A</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Fridman, Alma Levin</creator><creator>Raz, Aviad</creator><creator>Timmermans, Stefan</creator><creator>Shkedi-Rafid, Shiri</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220201</creationdate><title>Fragmented responsibility: views of Israeli HCPs regarding patient recontact following variant reclassification</title><author>Fridman, Alma Levin ; Raz, Aviad ; Timmermans, Stefan ; Shkedi-Rafid, Shiri</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-867792e8ccf67a29ee6335ac747256c91d7c872c8a1b6933d5fae8535c8dd9ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Epidemiology</topic><topic>Gene Function</topic><topic>Gene Therapy</topic><topic>Genomics</topic><topic>Health care</topic><topic>Human Genetics</topic><topic>Original</topic><topic>Original Article</topic><topic>Patients</topic><topic>Public Health</topic><topic>Reclassification</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fridman, Alma Levin</creatorcontrib><creatorcontrib>Raz, Aviad</creatorcontrib><creatorcontrib>Timmermans, Stefan</creatorcontrib><creatorcontrib>Shkedi-Rafid, Shiri</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of community genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fridman, Alma Levin</au><au>Raz, Aviad</au><au>Timmermans, Stefan</au><au>Shkedi-Rafid, Shiri</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fragmented responsibility: views of Israeli HCPs regarding patient recontact following variant reclassification</atitle><jtitle>Journal of community genetics</jtitle><stitle>J Community Genet</stitle><addtitle>J Community Genet</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>13</volume><issue>1</issue><spage>13</spage><epage>18</epage><pages>13-18</pages><issn>1868-310X</issn><eissn>1868-6001</eissn><abstract>While genomic medicine is becoming an important part of patient care with an ever-increasing diagnostic yield, recontacting patients after reclassification of variants of uncertain clinical significance (VUSs) remains a major challenge. Although periodical reinterpretation of VUSs is highly desired, recontacting former patients with new classifications is commonly not fulfilled in practice. We draw on semi-structured interviews with 20 Israeli healthcare professionals and stakeholders involved in communicating the results of genome-wide sequencing to patients. Findings show agreement that an individual health care professional cannot address the task of recontacting patients after re-classification, and that responsibility should be shared among the medical specialties, laboratory scientists, as well as patients. In the absence of established guidelines, many respondents suggested that the patient should be informed about reclassification during a follow-up contact but they disagreed who should be responsible for informing the patient. HCPs agreed that the solution to this challenge involves a centralized automated database that is accessible, continuously updated, and facilitates retrospective as well as prospective flagging of reclassification for patients who can benefit from this information. National and international policies providing concrete guidelines on the optimal way to recontact patients with new valuable genomic information are needed.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>34609721</pmid><doi>10.1007/s12687-021-00556-x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1868-310X |
ispartof | Journal of community genetics, 2022-02, Vol.13 (1), p.13-18 |
issn | 1868-310X 1868-6001 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8491183 |
source | Open Access: PubMed Central; Springer Nature |
subjects | Biomedical and Life Sciences Biomedicine Epidemiology Gene Function Gene Therapy Genomics Health care Human Genetics Original Original Article Patients Public Health Reclassification |
title | Fragmented responsibility: views of Israeli HCPs regarding patient recontact following variant reclassification |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T23%3A43%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fragmented%20responsibility:%20views%20of%20Israeli%20HCPs%20regarding%20patient%20recontact%20following%20variant%20reclassification&rft.jtitle=Journal%20of%20community%20genetics&rft.au=Fridman,%20Alma%20Levin&rft.date=2022-02-01&rft.volume=13&rft.issue=1&rft.spage=13&rft.epage=18&rft.pages=13-18&rft.issn=1868-310X&rft.eissn=1868-6001&rft_id=info:doi/10.1007/s12687-021-00556-x&rft_dat=%3Cproquest_pubme%3E2579379892%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-867792e8ccf67a29ee6335ac747256c91d7c872c8a1b6933d5fae8535c8dd9ee3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2623605355&rft_id=info:pmid/34609721&rfr_iscdi=true |